<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004843</url>
  </required_header>
  <id_info>
    <org_study_id>199/13926</org_study_id>
    <secondary_id>R01DK043858</secondary_id>
    <nct_id>NCT00004843</nct_id>
  </id_info>
  <brief_title>A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism</brief_title>
  <official_title>A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Henry Ford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Assess the efficacy of surgery vs no surgery in patients with mild
      asymptomatic primary hyperparathyroidism.

      II. Assess the quality of life, morbidity, and mortality of these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are stratified by gender.
      Patients are randomized to receive surgery or follow up without surgery.

      Patients receive parathyroidectomy (current standard care) or long term follow up without
      parathyroidectomy.

      Quality of life is assessed before the study and then every 6 months. All patients are
      followed every 6 months until death.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1997</start_date>
  <completion_date type="Actual">March 30, 1999</completion_date>
  <primary_completion_date type="Actual">March 30, 1999</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>2 years</time_frame>
    <description>Change in 9 SF 36 scores</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>Parathyroidectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>parathyroidectomy</intervention_name>
    <description>Standard parathyroidectomy with a bilateral approach</description>
    <arm_group_label>Parathyroidectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Usual care</description>
    <arm_group_label>Observation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics-- Histologically diagnosed mild asymptomatic primary
        hyperparathyroidism Persistent albumin adjusted serum calcium between 10.1-11.5 mg/dL for
        at least 3 months Intact parathyroid hormone greater than 20 pg/mL No other cause for
        hypercalcemia No family history of primary hyperparathyroidism, primary endocrine
        neoplasia, or hypocalciuric hypercalcemia Bone mineral density of the forearm no greater
        than 2.0 SD units below the expected value for sex, age, and race No phalangeal
        subperiosteal resorption on hand x-rays --Prior/Concurrent Therapy-- Radiotherapy: No
        history of childhood irradiation to head and neck Surgery: No thyroid disease requiring
        surgical intervention Other: No prior glucocorticoid or anticonvulsant drug therapy
        Concurrent thiazide diuretic therapy for hypertension must be changed to nonthiazides
        --Patient Characteristics-- Menopausal status: At least 5 years postmenopausal Renal: At
        least 2 years since prior nephrolithiasis Creatinine no greater than 1.5 mg/dL Creatinine
        clearance at least 70% (age adjusted) Cardiovascular: No unexpected finding on
        echocardiogram that will interfere with surgical intervention Other: Living within 150 mile
        radius of downtown Detroit No concurrent participation in other clinical trials No
        concurrent polyuria, polydipsia, anorexia, nausea, or vomiting At least 12 months since
        prior pancreatitis No concurrent symptomatic peptic ulcer disease No objective muscle
        weakness No history of nontraumatic vertebral or hip fractures No vertebral compression
        fractures No urolithiasis on x-ray of abdomen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D. Sudhaker Rao</last_name>
    <role>Study Chair</role>
    <affiliation>Henry Ford Hospital</affiliation>
  </overall_official>
  <results_reference>
    <citation>Talpos GB, Bone HG 3rd, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 2000 Dec;128(6):1013-20;discussion 1020-1.</citation>
    <PMID>11114637</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2000</study_first_submitted>
  <study_first_submitted_qc>February 24, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2000</study_first_posted>
  <last_update_submitted>May 25, 2017</last_update_submitted>
  <last_update_submitted_qc>May 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>disease-related problem/condition</keyword>
  <keyword>endocrine disorders</keyword>
  <keyword>hyperparathyroidism</keyword>
  <keyword>quality of life</keyword>
  <keyword>rare disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

